Company intelligence / Profile preview

LifeBank Chain

Pueblo, Colorado, United Stateslifebankusa.com ↗

Ownership: Private
Development stage: Commercial

Overview

LifeBank Chain is a clinical-stage biotechnology firm developing innovative gene and cell therapies. It also provides secure storage solutions for genetic data using blockchain technology. The team includes Nobel Prize-winning scientists. The company's R&D spans Singapore, Canada, China, and the US[5]. No specific clinical trial results are disclosed in public sources.

Therapeutic areas: Rare Diseases
Modalities: Gene therapyCell therapy
Industry: Biotech

Drug pipeline

2 assets

CYNK-001

Phase 1

Indications: Acute myeloid leukemia

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborations with research partners internationally.Supported by Nobel laureates Randy Schekman (Advisor) and Eric Maskin.

Beyond the preview

Go deeper on LifeBank Chain.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LifeBank Chain.

Explore the full profile